Gabriel K. Bell > Latham & Watkins LLP > Washington DC, United States > Lawyer Profile

Latham & Watkins LLP
555 ELEVENTH STREET, NW, SUITE 1000
WASHINGTON DC 20004-1304
DISTRICT OF COLUMBIA
United States

Position

Gabriel Bell is head of the firm’s Intellectual Property Appellate Practice and is regarded as one of the nation’s top IP appellate litigators. He represents market-leading technology and life sciences companies in the Federal Circuit and district courts. He is Chambers-ranked in IP Appellate and was recognized as the IP Appellate Litigator of the Year by LMG Life Sciences.

Gabriel combines his sophisticated technical knowledge with extensive experience in the Federal Circuit and federal district courts to guide clients across a broad range of sectors, including:

    • Computer
    • Telecommunication
    • Pharmaceutical
    • Biotech
    • Automotive
    • Financial

He has argued over 20 Federal Circuit appeals and has led and briefed dozens of others. He also routinely argues and briefs dispositive motions in district courts. He has particular expertise in patent eligibility under Section 101 of the Patent Act.

Gabriel serves as Co-Chair of the Federal Circuit Bar Association’s Scholarship Committee and maintains an active pro bono practice, including representing veterans in appeals.

Before joining Latham, Gabriel was counsel for the US Senate Committee on the Judiciary. He has also held positions at the US Department of Justice and NASA Langley Research Center. In addition, he clerked for judges on the D.C. and Fifth Circuits.

Gabriel is admitted to practice in the Supreme Court and the Fifth, Ninth, D.C., and Federal Circuits.

Career

https://www.lw.com/people/gabriel-bell

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

(Leading partners)

Gabriel K. Bell  –Latham & Watkins LLP

Recognised for its ‘strong track record of great results’, Latham & Watkins LLP’s team advises household names on complex, multi-patent and high-value patent litigation cases. As well as its market-leading pharmaceutical and life sciences patent practice, the ‘extremely sharp’ department has been growing a major technology offering for technology giants such as Netflix and Taiwan Semiconductor Manufacturing Corporation. The team demonstrates experience in all key litigation avenues, including the ITC and PTAB. David P. Frazier, from Washington DC, is a stand-out practitioner renowned for defending cutting-edge pharmaceutical products against infringing biosimilars. Frazier co-heads the department with Jennifer Barry, based in San Diego, and Austin’s Jeff Homrig. In Washington, DC, Gabriel K. Bell specializes in patent litigation in the Federal Circuit and District Courts. In New York City, Rachel Renee Blitzer, who was promoted to partnership in March 2024, focuses on complex patent and trade secret cases involving technologies, machinery, and medical devices. Douglas Lumish is well-regarded for his exceptional patent litigation record, and practices from the Bay Area. Maximilian Grant retired in December 2024.